Although CCL5 can bind to some chemokine receptors such as CCR1, CCR3 and CCR5, it is unclear which particular receptor is responsible for the pharmacologic CCL5 neutralization that can suppress cancer progression in mouse xenograft models [107]. This evidence concerns the gene CCR5 and cancer.